Skip to content

Novel Human C3 Derivatives for Therapeutic Complement Depletion

Complement depletion as a novel therapeutic approach, with applications in treating diseases with complement pathology.

Published: 29th July 2019
Novel Human C3 Derivatives for Therapeutic Complement Depletion
Please note, header image is purely illustrative. Source: skeeze, https://pixabay.com/photos/white-blood-cell-cell-blood-cell-543471/, CC0.
Patents
  • Granted US Patent (8,632,780) and Japan 6488376. Other applications pending.
IP Status
  • Patented
  • Patent application submitted
Seeking
  • Licensing
  • Commercial partner
  • Development partner
  • Seeking investment